Vimarsana
Biggest News Aggregation in the World

Page 13 - Mark Pearson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Pearson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Pearson Today - Breaking & Trending Today

Equitable (NYSE:EQH) Price Target Increased to $45.00 by Analysts at Jefferies Financial Group - Vimarsana News

Equitable (NYSE:EQH) Price Target Increased to $45.00 by Analysts at Jefferies Financial Group

Equitable (NYSE:EQH – Free Report) had its price target hoisted by Jefferies Financial Group from $42.00 to $45.00 in a research report sent to investors on Friday, Benzinga reports. The firm currently has a buy rating on the stock. Other equities research analysts have also recently issued research reports about the company. UBS Group boosted […]

Nepsis Introduces Corporate Retirement Division - Vimarsana News

Nepsis Introduces Corporate Retirement Division

Northwestern’s Trenton Hazen will lead new division and develop retirement plan services as the $500M RIA builds out a family office framework.

Entain, Rank, Betfred and Flutter join GC Industry Forum l - Vimarsana News

Entain, Rank, Betfred and Flutter join GC Industry Forum l

Directors of Flutter and Entain have been named among the nine appointed members of the Gambling Commission’s (GC) new Industry Forum.

Mark Pearson: Reporting from the NH House - Vimarsana News

Mark Pearson: Reporting from the NH House

Hello Eagle-Tribune readers, and hello again to those who loved the Carriage Towne News. A sister paper to the Tribune, Carriage Towne recently was discontinued, but I know readers have

Scripps Research celebrates 100 years of 'transformative scientific discoveries' in La Jolla - Vimarsana News

Scripps Research celebrates 100 years of 'transformative scientific discoveries' in La Jolla

Founded in 1924, the institute has been a major player in biomedical research and drug discovery for many diseases, and it has other frontiers in mind.